IP Library › Granted Patent US 10,245,282
Granted Patent B2
US 10,245,282 · App. 15/796,958 · Granted Apr 2, 2019

Compositions for sensitive skin

Inventors: David Gan (Southlake, TX); Tiffany Carle (Dallas, TX); Michelle Hines (Hickory Creek, TX); Milagros Sanchez (Dallas, TX); Patricia Jacoby (Dallas, TX); Linda Hart (Dallas, TX)
Assignee: MARY KAY INC.
A61K31/734A61K8/63A61K8/733A61K8/97A61K9/0014A61K31/704A61K36/28A61K36/33A61K36/896A61K38/011A61Q19/005
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,245,282
App. No.
15/796,958
Granted
Apr 2, 2019
Kind
B2
Abstract

Disclosed are compositions and methods for their use that include a combination of hydrolyzed algin, escin, Ruscus aculeatus root extract, ammonium glycyrrhizate, Centella asiatica extract, hydrolyzed yeast protein, and Calendula officinalis flower extract.

Claims (52)

1. A method of treating erythemic skin of a human in need thereof, the method comprising topically applying to the erythemic skin of said human in need thereof a composition comprising a therapeutically effective amount of:

(a) hydrolyzed algin;

(b) escin;

(c) Ruscus aculeatus root extract;

(d) ammonium glycyrrhizate;

(e) Centella asiatica extract;

(f) hydrolyzed yeast protein; and

(g) Calendula officinalis flower extract.

2. The method of claim 1 , wherein the composition reduces pro-inflamatory cytokine productin in the skin, and wherein the pro-inflammatory cytokine is TNF-a, IL-6, IL-8, IL-10, IL-12 p40, or GM-CSF.

3. The method of claim 1 , further comprising between 80 to 90% by weight of water.

4. The method of claim 1 , wherein said composition comprises:

(a) 0.005 to 0.05% by weight of hydrolyzed algin;

(b) 0.001 to 0.05% by weight of escin;

(c) 0.001 to 0.01% by weight of Ruscus aculeatus root extract;

(d) 0.001 to 0.01% by weight of ammonium glycyrrhizate;

(e) 0.0005 to 0.005% by weight of Centella asiatica extract;

(f) 0.0003 to 0.003% by weight of hydrolyzed yeast protein; and

(g) 0.0003 to 0.003% by weight of Calendula officinalis flower extract.

5. The method of claim 1 , wherein the composition further comprises butylene glycol;

glycerin; propylene glycol; diazolidinyl urea;

PPG-5-ceteth-20; methylparaben; sodium citrate; disodium EDTA; buteth-3; propylparaben; citric acid;

sodium benzotriazolyl butylphenol sulfonate; and panthenol.

6. The method of claim 1 , wherein the composition further comprises glycerin; pentylene glycol; glycereth-26; propylene glycol; triethanolamine;

acrylates/C10-30 alkyl acrylate crosspolymer;

diazolidinyl urea;

hydroxy ethylcellulose;

sodium polyacrylate;

methylparaben;

disodium EDTA;

butylene glycol;

phenoxy ethanol;

caprylyl glycol;

propylparaben; and

panthenol.

7. The method of claim 1 , wherein the composition further comprises pentylene glycol; polysilicone-11;

hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer;

dimethicone;

squalane;

glyceryl undecylenate; silica;

butylene glycol; triethanolamine; polysorbate 60;

acrylates/C10-30 alkyl acrylate crosspolymer;

hydroxypropyl cyclodextrin; sorbitan isostearate; panthenol; and glycerin.

8. The method of claim 1 , wherein the composition further comprises glycerin; pentylene glycol; glycereth-26; benzyl alcohol; triethanolamine;

acrylates/C10-30 alkyl acrylate crosspolymer;

hydroxy ethylcellulose;

sodium polyacrylate;

di sodium EDTA;

hydroxypropyl cyclodextrin;

butylene glycol;

phenoxy ethanol;

caprylyl glycol; and

panthenol.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 14, 2025
From: MARY KAY INC.
To: ALLUSTRA TECHNOLOGIES LLC
Reel/Frame 071690/0206 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 30, 2017
From: GAN, DAVID; CARLE, TIFFANY; HINES, MICHELLE; SANCHEZ, MILAGROS; JACOBY, PATRICIA; HART, LINDA
To: MARY KAY INC.
Reel/Frame 043978/0913 →
Continuity (5)
Continuation 14550664 · Nov 21, 2014
Provisional Application 61907836 · Nov 22, 2013
Provisional Application 61913551 · Dec 9, 2013
Provisional Application 61921803 · Dec 30, 2013
Related Publication 20180085393A1 · Mar 29, 2018